Leishmania
Researchers from India and the United States describe findings in leishmania studies
Published in Medical Letter on the CDC and FDA, July 9th, 2006
Study 1: Non-phosphatidylcholine liposome-entrapped promastigote antigens elicit parasite-specific CD8+ and CD4+ T-cell immune responses and protect hamsters against visceral leishmaniasis.
According to recent research published in the journal Vaccine, "Leishmania donovani promastigote soluble antigens (sLAg) were encapsulated in non-phosphatidylcholine (non-PC) liposomes (escheriosomes) prepared from E. coli lipids. The escheriosome-based vaccine was investigated for its potential to elicit a protective immune response against experimental visceral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Food-Borne Illness
Salmonella Heidelberg outbreaks in U.S. traced to poultry and eggs - Food-Borne Illness
Aging of cheese made from unpasteurized milk does not eliminate Escherichia coli O157:H7 - HIV/AIDS Diagnosis
HIV RNA testing improves diagnosis of HIV infection in high-risk patients - Hepatitis E Virus
Locally acquired hepatitis E virus infection in Texas reported - Sexual & Reproductive Health
High-risk behaviors linked to Viagra use among men who have sex with men - Acute Myelogenous Leukemia
CuraGen and TopoTarget announce NCI-sponsored Phase II clinical trial with PXD101 for AML - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
